467 related articles for article (PubMed ID: 28031389)
1. Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.
Chamberlain MC; Baik CS; Gadi VK; Bhatia S; Chow LQ
Neuro Oncol; 2017 Jan; 19(1):i1-i24. PubMed ID: 28031389
[TBL] [Abstract][Full Text] [Related]
2. Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study.
Siena S; Crinò L; Danova M; Del Prete S; Cascinu S; Salvagni S; Schiavetto I; Vitali M; Bajetta E
Ann Oncol; 2010 Mar; 21(3):655-661. PubMed ID: 19767314
[TBL] [Abstract][Full Text] [Related]
3. Targeted and immunotherapeutic approaches in brain metastases.
Ahluwalia MS; Winkler F
Am Soc Clin Oncol Educ Book; 2015; ():67-74. PubMed ID: 25993144
[TBL] [Abstract][Full Text] [Related]
4. Molecular subtyping of brain metastases and implications for therapy.
Renfrow JJ; Lesser GJ
Curr Treat Options Oncol; 2013 Dec; 14(4):514-27. PubMed ID: 23907440
[TBL] [Abstract][Full Text] [Related]
5. Systemic treatments for brain metastases from breast cancer, non-small cell lung cancer, melanoma and renal cell carcinoma: an overview of the literature.
Lombardi G; Di Stefano AL; Farina P; Zagonel V; Tabouret E
Cancer Treat Rev; 2014 Sep; 40(8):951-9. PubMed ID: 24909312
[TBL] [Abstract][Full Text] [Related]
6. Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis.
Tian J; Luo Y; Xiang J; Tang J
J Neurooncol; 2017 Nov; 135(2):217-227. PubMed ID: 28726172
[TBL] [Abstract][Full Text] [Related]
7. Checkpoint inhibitors in the treatment of brain metastases of non-small-cell lung cancer and melanoma.
Kourie HR; Kanaan H; Awada G; Awada AH
Future Oncol; 2017 May; 13(12):1097-1103. PubMed ID: 28326837
[TBL] [Abstract][Full Text] [Related]
8. Paradigm shift of therapeutic management of brain metastases in EGFR-mutant non-small cell lung cancer in the era of targeted therapy.
Sekine A; Satoh H
Med Oncol; 2017 Jul; 34(7):121. PubMed ID: 28555261
[TBL] [Abstract][Full Text] [Related]
9. Management of Non-Small-Cell Lung Cancer Patients Initially Diagnosed With 1 to 3 Synchronous Brain-Only Metastases: A Retrospective Study.
Chen XR; Hou X; Li DL; Sai K; Dinglin XX; Chen J; Wang N; Li MC; Wang KC; Chen LK
Clin Lung Cancer; 2021 Jan; 22(1):e25-e34. PubMed ID: 32839132
[TBL] [Abstract][Full Text] [Related]
10. Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG).
Christodoulou C; Kalogera-Fountzila A; Karavasilis V; Kouvatseas G; Papandreou CN; Samantas E; Varaki K; Papadopoulos G; Bobos M; Rallis G; Razis E; Goudopoulou A; Kalogeras KT; Syrigos KN; Fountzilas G
J Neurooncol; 2017 Sep; 134(2):443-451. PubMed ID: 28687923
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
Deng X; Zheng Z; Lin B; Su H; Chen H; Fei S; Fei Z; Zhao L; Jin X; Xie CY
BMC Cancer; 2017 Jan; 17(1):42. PubMed ID: 28068937
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy in combination with systemic therapies for brain metastases: current status and progress.
Liu L; Chen W; Zhang R; Wang Y; Liu P; Lian X; Zhang F; Wang Y; Ma W
Cancer Biol Med; 2020 Nov; 17(4):910-922. PubMed ID: 33299643
[TBL] [Abstract][Full Text] [Related]
13. Response rate and local recurrence after concurrent immune checkpoint therapy and radiotherapy for non-small cell lung cancer and melanoma brain metastases.
Qian JM; Martin AM; Martin K; Hammoudeh L; Catalano PJ; Hodi FS; Cagney DN; Haas-Kogan DA; Schoenfeld JD; Aizer AA
Cancer; 2020 Dec; 126(24):5274-5282. PubMed ID: 32926760
[TBL] [Abstract][Full Text] [Related]
14. Expression profiling of angiogenesis-related genes in brain metastases of lung cancer and melanoma.
Ilhan-Mutlu A; Siehs C; Berghoff AS; Ricken G; Widhalm G; Wagner L; Preusser M
Tumour Biol; 2016 Jan; 37(1):1173-82. PubMed ID: 26277786
[TBL] [Abstract][Full Text] [Related]
15. Optimal management of brain metastases in oncogenic-driven non-small cell lung cancer (NSCLC).
Andratschke N; Kraft J; Nieder C; Tay R; Califano R; Soffietti R; Guckenberger M
Lung Cancer; 2019 Mar; 129():63-71. PubMed ID: 30797493
[TBL] [Abstract][Full Text] [Related]
16. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
Singh C; Qian JM; Yu JB; Chiang VL
J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
[TBL] [Abstract][Full Text] [Related]
17. Treatment of brain metastases of lung cancer in the era of precision medicine.
Haughton ME; Chan MD; Watabe K; Bonomi M; Debinski W; Lesser GJ; Ruiz J
Front Biosci (Elite Ed); 2016 Jan; 8(1):219-32. PubMed ID: 26709658
[TBL] [Abstract][Full Text] [Related]
18. Systemic therapy for brain metastases.
Rick JW; Shahin M; Chandra A; Dalle Ore C; Yue JK; Nguyen A; Yagnik G; Sagar S; Arfaie S; Aghi MK
Crit Rev Oncol Hematol; 2019 Oct; 142():44-50. PubMed ID: 31357143
[TBL] [Abstract][Full Text] [Related]
19. Non-small cell lung cancer brain metastases and the immune system: From brain metastases development to treatment.
El Rassy E; Botticella A; Kattan J; Le Péchoux C; Besse B; Hendriks L
Cancer Treat Rev; 2018 Jul; 68():69-79. PubMed ID: 29883857
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the inflammatory response to solid cancer metastases in the human brain.
Berghoff AS; Lassmann H; Preusser M; Höftberger R
Clin Exp Metastasis; 2013 Jan; 30(1):69-81. PubMed ID: 22752508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
